Buscar
01/03/2024
Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics
Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2024; 23(1)DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2.500(Q3/7D).
01/03/2024
Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study
Vlacho, B, Fernandez-Camins, B, Canudas-Ventura, A, Rodríguez, A, Mollo, A, Claramunt, FXC, Antentas, M, Mauricio, D, Franch-Nadal, J. Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 2024; 13(6)DOI:10.3390/jcm13061544. PMID:38541770. IF:2.900(Q1/2D).
01/03/2024
A comprehensive examination of small-bowel capsule endoscopy in Spanish centers to meet European Society of Gastrointestinal Endoscopy standards
Villagrá, MG, de Frías, CP, de la Mata, DMA, Alonso-Sierra, M, Alonso-Lazaro, N, Caballero, N, Ceballos, FS, Compañy, L, Valenzuela, JE, Esteban, P, Farráis, S, Fernández-Urién, I, Galvez, C, García, A, Lledó, JG, Suárez, BG, Jiménez-García, VA, Lujan-Sanchís, M, Muñoz, BM, Romero-Mascarell, C, Acosta, MS, Cortázar, EV, Giordano, A, Carretero, C. A comprehensive examination of small-bowel capsule endoscopy in Spanish centers to meet European Society of Gastrointestinal Endoscopy standards. Endoscopy International Open. 2024; 12(03)DOI:10.1055/a-2252-8946. PMID:38481597. IF:(Q/D).
01/03/2024
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
Fernández-Lozano, D, Hernández-Rodríguez, I, Narvaez, J, Domínguez-Alvaro, M, De Miguel, E, Silva-Díaz, M, Belzunegui, JM, Morales, CM, Sánchez, J, Galíndez-Agirregoikoa, E, Aldaroso, V, Abasolo, L, Loricera, J, Garrido-Puñal, N, Alvarado, PM, Larena, C, Navarro, VA, Calvet, J, Casafont-Solé, I, Ortiz-Sanjuán, F, Monte, TCS, Castañeda, S, Blanco, R. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register. RMD Open. 2024; 10(1)DOI:10.1136/rmdopen-2023-003824. PMID:38531620. IF:4.700(Q1/1D).
01/03/2024
Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion
Casademont, EB, Molina, JM. Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion. Angiologia. 2024; 76(2)DOI:10.20960/angiologia.00496. PMID:. IF:(Q/D).
01/03/2024
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)
Di Giacomo, AM, Schenker, M, Medioni, J, Mandziuk, S, Majem, M, Gravis, G, Cornfeld, M, Ranganathan, S, Lou, S, Csoszi, T. A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203). ESMO Open. 2024; 9(3)DOI:10.1016/j.esmoop.2024.102387. PMID:38401247. IF:8.300(Q1/2D).
01/03/2024
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms (vol 13, 1223282, 2023)
Grünwald, V, Powles, T, Eto, M, Kopyltsov, E, Rha, SY, Porta, C, Motzer, R, Hutson, TE, Méndez-Vidal, MJ, Hong, SH, Winquist, E, Goh, JC, Maroto, P, Buchler, T, Takagi, T, Burgents, JE, Perini, R, He, CX, Okpara, CE, McKenzie, J, Choueiri, TK. Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms (vol 13, 1223282, 2023). Frontiers in Oncology. 2024; 13DOI:10.3389/fonc.2023.1343027. PMID:38495081. IF:3.300(Q2/4D).
01/03/2024
What About Variant Histologies in Bladder Cancer?
Day, E, Gavira, J, Tapia, JC, Anguera, G, Maroto, P. What About Variant Histologies in Bladder Cancer?. European Urology Focus. 2024; 10(2)DOI:10.1016/j.euf.2024.05.015. PMID:38849276. IF:5.600(Q1/1D).